4.92
-1.08 (-18.02%)
| Previous Close | 6.00 |
| Open | 5.67 |
| Volume | 7,776,507 |
| Avg. Volume (3M) | 6,383,984 |
| Market Cap | 1,067,566,464 |
| Price / Earnings (Forward) | 16.00 |
| Price / Sales | 1.32 |
| Price / Book | 0.450 |
| 52 Weeks Range | |
| Earnings Date | 28 Jul 2025 - 1 Aug 2025 |
| Profit Margin | -53.56% |
| Operating Margin (TTM) | 2.45% |
| Diluted EPS (TTM) | -2.23 |
| Quarterly Revenue Growth (YOY) | -3.40% |
| Total Debt/Equity (MRQ) | 33.61% |
| Current Ratio (MRQ) | 3.91 |
| Operating Cash Flow (TTM) | 68.45 M |
| Levered Free Cash Flow (TTM) | 1.26 M |
| Return on Assets (TTM) | 0.59% |
| Return on Equity (TTM) | -16.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bearish | Bearish |
| Diagnostics & Research (Global) | Bearish | Bearish | |
| Stock | Neogen Corporation | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | 3.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -0.5 |
| Average | 1.50 |
|
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Core |
| % Held by Insiders | 0.38% |
| % Held by Institutions | 128.86% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 13.00 (Guggenheim, 164.29%) | Buy |
| Median | 9.00 (82.97%) | |
| Low | 5.00 (Piper Sandler, 1.65%) | Hold |
| Average | 9.00 (82.97%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 5.19 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 22 Apr 2025 | 5.00 (1.65%) | Hold | 4.75 |
| 14 Apr 2025 | 6.50 (32.15%) | Hold | 5.40 | |
| Guggenheim | 10 Apr 2025 | 13.00 (164.29%) | Buy | 5.63 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Jun 2025 | Announcement | Neogen Launches Second Edition Environmental Monitoring Handbook to Elevate Food Safety Practices |
| 21 May 2025 | Announcement | Neogen® to Participate in the 45th Annual William Blair Growth Stock Conference |
| 13 May 2025 | Announcement | Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. Tobin |
| 21 Apr 2025 | Announcement | Neogen Announces Sale of Cleaners & Disinfectants Business |
| 09 Apr 2025 | Announcement | Neogen® Announces CEO Transition |
| 09 Apr 2025 | Announcement | Neogen Announces Third-Quarter 2025 Results |
| 07 Apr 2025 | Announcement | Neogen® Announces Refinancing of Term Loan and Revolving Credit Facility |
| 20 Mar 2025 | Announcement | Neogen Announces Third-Quarter Earnings Release Date |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |